Global Drug-Eluting Stent Market 2016-2020; New Report Launched

DrugPipeline.net has announced the addition of “Global Drug-Eluting Stent Market 2016-2020” research report to their website DrugPipeline.net

Logo

Bangalore, Karnataka -- (SBWire) -- 03/31/2016 --Drug-eluting stents, also known as medicated coronary stents, are used to inhibit artery blockages that may occur in patients after an angioplasty surgery. A drug-eluting stent is a tiny, expandable metal mesh tube, which is covered with a pharmacologic agent (drug). Drug-eluting stents are used to treat patients that suffer from atherosclerosis that can occur because of hypertension, smoking, a sedentary lifestyle, or a high-cholesterol diet. After a patient undergoes angioplasty, there is a chance that the artery might close again because of blood clots or excessive growth of the surrounding tissues. To address this problem, drug-eluting stents are placed in the artery, preventing it from narrowing or clogging. Thus, drug-eluting stents eliminate the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Restenosis of an artery occurs because of the body's natural immune response to an injury. Drug-eluting stents help in reducing the arterial blockage and ensure smooth blood flow through the arteries.

Report forecast the global drug-eluting stent market to grow at a CAGR of 3.45% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global drug-eluting stent market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drug-eluting stent products.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Drug-Eluting Stent Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Laboratories
- Biosensors International Group
- Boston Scientific
- Medtronic
- Terumo Corporation

Other prominent vendors
- Biotronik
- Cook Medical
- Envision Scientific
- Lepu Medical
- Meril Life Sciences
- MicroPort Medical
- Opto Circuits
- Shandong JW Medical Systems
- STENTYS

Market driver
- High prevalence of atherosclerosis diseases
- For a full, detailed list, view our report

Market challenge
- Decline in price of drug-eluting stent
- For a full, detailed list, view our report

Market trend
- Increasing partnership and collaboration activities
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 56 pages "Global Drug-Eluting Stent Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Drug-eluting stents: An overview, Market landscape, Drugs employed in drug-eluting stents, Geographical segmentation, Key leading countries, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-drug-eluting-stent-market-2016-2020

Related Reports:

Global Choroidal Neovascularization Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-choroidal-neovascularization-market-2016-2020

Global Rhematoid Arthritis Drugs Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-rhematoid-arthritis-drugs-market-2016-2020

Global E. Coli Testing Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-e-coli-testing-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.

Media Relations Contact

Sudeep Chakravarty
General Manager - Operations
DrugPipeline.net
302-703-7787
http://www.drugpipeline.net/

View this press release online at: http://rwire.com/677207